Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Short Interest Update
Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF – Get Rating) saw a large drop in short interest in August. As of August 31st, there was short interest totalling 100 shares, a drop of 93.3% from
kopsourceSep 14, 2022 12:52 ET
CSE Bulletin: Name and Symbol Change - Ortho Regenerative Technologies Inc. (ORTH)
Toronto, Ontario--(Newsfile Corp. - Le 7 septembre/September 2022) - Ortho Regenerative Technologies Inc. (ORTH) has announced a name and symbol change to ChitogenX Inc. (CHGX) Shares will begin tradi
newsfileSep 7, 2022 12:20 ET
Ortho Regenerative Technologies Announces Name Change to ChitogenX Inc.
Ortho Regenerative Technologies (OTCQB:ORTIF) has changed its corporate name to ChitogenX Inc. The new name to better represent company's proprietary technology platform expanded applications beyond
Seeking AlphaSep 7, 2022 07:26 ET
Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Sees Significant Increase in Short Interest
Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF – Get Rating) was the recipient of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling
kopsourceAug 27, 2022 22:41 ET
Ortho Regenerative Technologies GAAP EPS of -C$0.02
Ortho Regenerative Technologies press release (OTCQB:ORTIF): Q1 GAAP EPS of -C$0.02. Cash balance as April 30, 2022 of C$2.19M
Seeking AlphaJun 24, 2022 07:18 ET
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL
Contracting procedures completed for 6 of the 10 clinical trial sites 5 sites fully activated, with ongoing patients' screening and recruitment MONTREAL, June 13, 2022 /PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE:ORTH) (OTCQB:ORTIF) ("O
PR NewswireJun 13, 2022 08:46 ET
Ortho Regenerative Technologies; GAAP EPS of -C$0.14
Ortho Regenerative Technologies press release (OTCQB:ORTIF): FY GAAP EPS of -C$0.14.Cash Balance of C$314K as of January 31, 2022
Seeking AlphaMay 20, 2022 08:07 ET
Ortho Regenerative gets US patent related to its soft tissue repair platform
Ortho Regenerative Technologies (OTCQB:ORTIF) said the U.S. Patent and Trademark Office (USPTO) issued a patent related to the company's ORTHO-R soft tissue repair platform. The company said the US Pa
Seeking AlphaMay 4, 2022 08:47 ET
Ortho Regenerative Technologies to raise C$3M in private placement offering
Ortho Regenerative Technologies (OTCQB:ORTIF) announced Friday a private placement offering of C$3M units priced at C$0.30 each. The company said proceeds will be used for the ORTHO-R Phase I/II US Cl
Seeking AlphaFeb 11, 2022 08:46 ET
CN.ORTH: Clinical Hold Lifted in Time for 3Q:22 Results
By John Vandermosten, CFACNSX:ORTH.CN | OTC:ORTIFREAD THE FULL ORTH.CN RESEARCH REPORTClinical Hold Letter LiftedFollowing the April 2021 Investigational New Drug (IND) submission for Ortho-R, Ortho R
Benzinga Real-time NewsDec 27, 2021 12:36 ET
BRIEF-Ortho Regenerative Technologies Announces Filing Of Response To Type A Meeting With FDA And Non-Brokered $1.5 Mln Private Placement
Nov 12 (Reuters) - Ortho Regenerative Technologies IncORTH.CD :* ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES FILING OF RESPONSE TO TYPE A MEETING WITH FDA AND NON-BROKERED $1.5 MILLION PRIVATE PLACEMENT
reutersNov 12, 2021 07:26 ET
CN.ORTH: New Blood on The Board
By John Vandermosten, CFACNSX:ORTH.CN | OTC:ORTIFREAD THE FULL ORTH.CN RESEARCH REPORTSecond Quarter Fiscal Year 2022 Operational and Financial ResultsOn September 30, 2021, Ortho Regenerative Technol
Benzinga Real-time NewsOct 30, 2021 05:32 ET
Ortho Regenerative Technologies Announces "Successful" Type A Meeting With U.S. FDA on CMC Elements
03:04 PM EDT, 10/06/2021 (MT Newswires) -- Ortho Regenerative Technologies Inc. (ORTH.CSE), a clinical stage orthobiologics company developing soft tissue repair regenerative technologies, on Wednesd
MT NewswiresOct 6, 2021 15:06 ET
BRIEF-Ortho Regenerative Technologies Announces Successful Type A Meeting With U.S. FDA On CMC Elements
Oct 6 (Reuters) - Ortho Regenerative Technologies IncORTH.CD :* ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES SUCCESSFUL TYPE A MEETING WITH U.S. FDA ON CMC ELEMENTS FOR WHICH MORE INFORMATION WAS REQUIRE
reutersOct 6, 2021 13:50 ET
Ortho Regenerative Technologies reports Q2 results
Ortho Regenerative Technologies (OTCQB:ORTIF): Q2 GAAP EPS of C$0.03.Cash balance of C$855KPress Release
Seeking AlphaSep 30, 2021 17:54 ET
Press Release: Ortho Regenerative Technologies Reports Its Second Quarter 2022 Results
Press Release: Ortho Regenerative Technologies Reports Its Second Quarter 2022 Results Ortho Regenerative Technologies Reports Its Second Quarter 2022 Results Canada NewsWire MONTREAL, QC, Sep
Dow Jones NewswiresSep 30, 2021 17:32 ET
No Data
No Data